Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-03-28FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' supplemental ANDA for a generic combination of amphetamine/dextroamphetamine salts used to treat attention…
-
FDA approval · 2024-03-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for methylphenidate hydrochloride, a generic stimulant product, enabling it…
-
FDA approval · 2024-03-12FDA Approved: COTEMPLA XR-ODT — Supplemental Application (Neos Therapeutics Brands, LLC)
The FDA approved a supplemental NDA for Cotempla XR-ODT, a methylphenidate product from Neos Therapeutics Brands, LLC.
-
FDA approval · 2024-03-08FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (KVK-Tech, Inc.)
FDA approved a supplemental application for dextroamphetamine sulfate from KVK-Tech, Inc., making the generic product available via an appro…
-
FDA approval · 2024-02-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride from Sun Pharmaceutical Industries, expanding the approval status …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-02-27FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Eywa Pharma Inc)
FDA approves Eywa Pharma Inc's supplemental application for methylphenidate hydrochloride, a generic ADHD medication, under an ANDA.
-
FDA approval · 2024-02-27FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Granules Pharmaceuticals' combination amphetamine salts product (dextroamphetamine saccharate, a…
-
FDA approval · 2024-02-27FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application from Granules Pharmaceuticals Inc. for a generic product containing four amphetamine/dextroamphetami…
-
FDA approval · 2024-02-27FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride from Sun Pharmaceutical Industries, Inc. under the ANDA framewo…
-
FDA approval · 2024-02-20FDA Approved: GUANFACINE EXTENDED-RELEASE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for guanfacine extended-release from Apotex Corp., enabling the generic product's approval.
-
FDA approval · 2024-02-14FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for lisdexamfetamine dimesylate (generic) from Lannett Company, Inc., enabling a new generic pro…
-
FDA approval · 2024-02-12FDA Approved: ATOMOXETINE — Supplemental Application (Northstar Rx LLC)
FDA approves a supplemental application for atomoxetine from Northstar Rx LLC under ANDA 079019, enabling a generic version of the ADHD medi…
-
FDA approval · 2024-02-08FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride from Granules Pharmaceuticals Inc. Dexmethylphenidate hydrochlo…
-
FDA approval · 2024-02-07FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Supplemental Application (Mayne Pharma Commercial LLC)
FDA approved a supplemental application for methamphetamine hydrochloride (Mayne Pharma Commercial LLC).
-
FDA approval · 2024-02-02FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an original ANDA for lisdexamfetamine dimesylate (Novadoz Pharmaceuticals LLC), a generic version of the stimulant used to trea…
-
FDA approval · 2024-01-30FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for lisdexamfetamine dimesylate by Apotex Corp., approving a generic product under the supplemental …
-
FDA approval · 2024-01-26FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (NorthStar RxLLC)
FDA approved NorthStar RxLLC's supplemental application for a generic four-salt amphetamine/dextroamphetamine product (dextroamphetamine sac…
-
FDA approval · 2024-01-26FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Oryza Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic product containing four amphetamine salts (dextroamphetamine saccharate, amphetamine a…
-
FDA approval · 2024-01-16FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for amphetamine sulfate manufactured by Aurolife Pharma, LLC.
-
FDA approval · 2024-01-11FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Trigen Laboratories, LLC)
FDA approved a supplemental application for methylphenidate hydrochloride from Trigen Laboratories, LLC.
-
FDA approval · 2024-01-05FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for lisdexamfetamine dimesylate, a generic version of the ADHD medication.
-
FDA approval · 2023-10-20FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII — Supplemental Application (Alvogen Inc.)
FDA approves Alvogen Inc.'s supplemental application to market generic mixed amphetamine salts tablets (dextroamphetamine/amphetamines) in m…
-
FDA approval · 2023-10-20FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for methylphenidate hydrochloride (generic). This approval supports the ava…
-
FDA approval · 2023-10-20FDA Approved: DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application from SpecGx LLC for a generic product containing dextroamphetamine saccharate and amphetamine aspart…
-
FDA approval · 2023-10-18FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for Amphetamine Sulfate from Solco Healthcare US, LLC.